Alps Advisors Inc

SEC CIK: 0001376113
Latest filing: Jul 29, 2026

SEC filings (opens in a new tab)

NGNE holding history

Neurogene Inc. in every 13F filed by Alps Advisors Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NGNE overview All 13F holders of NGNE Full Q2 2026 holdings

Shares (Q2 2026): 16,040
Value: $504.5K
% of portfolio: <0.1%
Quarters held: 3; Since Q4 2025

Holdings of NGNE by Alps Advisors Inc, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	16,040	$504.5K	<0.1%	+3,434+27.2%	Added	Holders
Q1 2026	12,606	$254.1K	<0.1%	−115−0.9%	Reduced	Holders
Q4 2025	12,721	$262.1K	<0.1%	+12,721	New	Holders